Warfarin
Warfarin is a pharmaceutical drug with 299 clinical trials. Currently 20 active trials ongoing. Historical success rate of 93.3%.
Success Metrics
Based on 210 completed trials
Phase Distribution
Phase Distribution
83
Early Stage
35
Mid Stage
108
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
89.7%
210 of 234 finished
10.3%
24 ended early
20
trials recruiting
299
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
Clinical Trials (299)
Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation
An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates
Determinants of Warfarin Metabolism
Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin
Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin
Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves
SWITCH: Apixaban vs Vitamin K in HM3
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.
A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 299